Epileptic myoclonus as ciprofloxacin-associated adverse effect [8]

Movement Disorders

Volumn 22, Issue 11, 2007, Pages 1675-1676

  Striano, Pasquale ^a   Zara, Federico ^a   Coppola, Antonietta ^b   Ciampa, Clotilde ^b   Pezzella, Marianna ^b   Striano, Salvatore ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LORAZEPAM;

ADULT; ANTIBIOTIC THERAPY; CASE REPORT; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; HUMAN; LETTER; MALE; MYOCLONUS EPILEPSY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSORY STIMULATION; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; ELECTROMYOGRAPHY; EPILEPSY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCLONUS;

EID: 34748852113     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21456     Document Type: Letter

References (5)

1. De Sarro A, De Sarro G. Adverse reactions to fluoroquinolones. An overview on mechanistic aspects. Curr Med Chem 2001;8:371-384.
2. Schwartz MT, Calvert JF. Potential neurologic toxicity related to ciprofloxacin. Ann Pharmacother 1990;24:138-140.
3. Farrington J, Stoudemire A, Tierney J. The role of ciprofloxacin in a patient with delirium due to multiple etiologies. Gen Hosp Psychiatry 1995;17:47-53.
4. Post B, Koelman JHTM, Tijssen MAJ. Propriospinal myoclonus after treatment with ciprofloxacin. Mov Disord 2004;19:595-597.
5. Tsutomi Y, Matsubayashi K, Akahane K. Quantitation of GABAA receptor inhibition required for quinolone-induced convulsions in mice. J Antimicrob Chemother 1994;34:737-746.